DrugSupplement
Pterostilbene clinical trials
Keep track of what changes. Save the pterostilbene studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
- NRPT
- 1
Studies by the year they started
6 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 5
City of Hope Medical Center (1) · Mayo Clinic (1) · Massachusetts General Hospital (1) · University of Mississippi Medical Center (1) · Biogipuzkoa Health Research Institute (1) · Elysium Health (1)
Often tested with
Tested in the same studies.
Nicotinamide-beta-riboside (4) · Whole grape extract (1) · Acetylcysteine (1)
Studies
Open first, then newest update. How each study uses pterostilbene is read from its arms, and is right about nine times in ten.
Testing it · 6
- Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)RecruitingPhase 1/2Biogipuzkoa Health Research InstituteNCT07414212Written as EH301
- Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing HysterectomyActive, not recruitingPhase 2City of Hope Medical CenterNCT03671811Written as Pterostilbene
- Protection From Acute Kidney Injury (AKI) With Basis™ TreatmentCompletedPhase 2Mayo ClinicNCT04342975Written as Nicotinamide Riboside + Pterostilbene
- Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET)Status unknownPhase 1Elysium HealthNCT03635411Written as Nicotinamide Riboside and Pterostilbene
- Pharmacokinetics, Pharmacodynamics and Safety of Basis in Acute Kidney Injury StudyCompletedNot applicableMassachusetts General HospitalNCT03176628Written as Basis
- Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative StressCompletedPhase 2/3University of Mississippi Medical CenterNCT01267227Written as Pterostilbene 50 mg twice daily
Given in every arm · 1 — pterostilbene is usual care beside what is tested
Codes
What other systems call pterostilbene · ClinicalTrials.gg INT004010
- MeSH (NLM) C107773pterostilbeneOne source NLM
- UNII (FDA) 26R60S6A5IPTEROSTILBENEConfirmed FDA, NLM, Wikidata
- Wikidata Q2908011pterostilbeneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C153353PterostilbeneOne source FDA
- DrugBank DB17939One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C107773 | pterostilbene | One source NLM |
| UNII (FDA) | 26R60S6A5I | PTEROSTILBENE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q2908011 | pterostilbene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C153353 | Pterostilbene | One source FDA |
| DrugBank | DB17939 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.